Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1-2
pubmed:dateCreated
2005-12-27
pubmed:abstractText
This study aimed at investigating if selective ex vivo immune deviation of myelin-specific cytokine secretion towards Th2 is possible in blood cells from patients with multiple sclerosis (MS). Interleukin (IL)-4 (Th2) and interferon-gamma (Th1) secreting cells were recorded by ELISPOT in 13 MS patients. Deviation was successful in 10 patients. Interleukin-4 alone was most effective in inducing myelin-specific immune deviation in MS patients whereas IL-1 or IL-15 in combination with IL-4 did not improve the results. Further studies and improvements are needed before ex vivo immune deviation can be considered a potential treatment in patients with MS.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0165-5728
pubmed:author
pubmed:issnType
Print
pubmed:volume
171
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
156-62
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:16256209-Adult, pubmed-meshheading:16256209-Aged, pubmed-meshheading:16256209-Cell Culture Techniques, pubmed-meshheading:16256209-Enzyme-Linked Immunosorbent Assay, pubmed-meshheading:16256209-Female, pubmed-meshheading:16256209-Humans, pubmed-meshheading:16256209-Immunization, pubmed-meshheading:16256209-Interferon-gamma, pubmed-meshheading:16256209-Interleukin-4, pubmed-meshheading:16256209-Lymphocyte Activation, pubmed-meshheading:16256209-Male, pubmed-meshheading:16256209-Middle Aged, pubmed-meshheading:16256209-Multiple Sclerosis, pubmed-meshheading:16256209-Myelin Proteins, pubmed-meshheading:16256209-Myelin Sheath, pubmed-meshheading:16256209-Myelin-Associated Glycoprotein, pubmed-meshheading:16256209-T-Lymphocytes, pubmed-meshheading:16256209-Th2 Cells, pubmed-meshheading:16256209-Time Factors
pubmed:year
2006
pubmed:articleTitle
In vitro Th2 deviation of myelin-specific peripheral blood lymphocytes from patients with multiple sclerosis.
pubmed:affiliation
Division of Clinical Immunology, Sweden.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't